Table 3.
Univariate Analysis of Clinical and Paraclinical Factors Associated With Hypoglycemia <54 mg/dL.
| RR | 95% CI | P | |
|---|---|---|---|
| Clinical variable | |||
| Age | 1.00 | 0.97-1.03 | .830 |
| Female gender | 1.07 | 0.54-2.15 | .840 |
| BMI | 0.91 | 0.83-0.99 | .046 |
| Time since diagnosis (years) | 1.04 | 1.00-1.08 | .038 |
| Polypharmacy | 1.33 | 0.51-3.48 | .564 |
| Hypoglycemia history | |||
| History of severe hypoglycemia by clinic | 0.74 | 0.27-2.08 | .579 |
| History of hypoglycemia <54 mg/dl in the last 3 months | 1.31 | 0.65-2.63 | .451 |
| History of asymptomatic hypoglycemia in the last 3 months | 1.10 | 0.49-2.50 | .815 |
| Paraclinical variables | |||
| HbA1c | 0.91 | 0.72-1.17 | .473 |
| Mean glucose | 0.98 | 0.96-0.99 | .022 |
| Creatinine | 0.84 | 0.52-1.36 | .491 |
| GFR | 1 | 0.99-1.01 | .883 |
| Microalbumin/creatinine ratio | 0.99 | 0.99-1.00 | .552 |
Hypoglycemia history determined by direct interview and review of the patient’s clinical records. Polypharmacy defined as the use of five or more medications.